相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Induction of Podocyte VEGF164 Overexpression at Different Stages of Development Causes Congenital Nephrosis or Steroid-Resistant Nephrotic Syndrome
Delma Veron et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Pathologic Classification of Diabetic Nephropathy
Thijs W. Cohen Tervaert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Major contribution of tubular secretion to creatinine clearance in mice
Christoph Eisner et al.
KIDNEY INTERNATIONAL (2010)
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease
Delma Veron et al.
KIDNEY INTERNATIONAL (2010)
Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice
Tomoki Kosugi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development
Kimberly J. Reidy et al.
DEVELOPMENT (2009)
Mouse Models of Diabetic Nephropathy
Frank C. Brosius et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Advanced glycation end-products suppress neuropilin-1 expression in podocytes
Tzvetanka Bondeva et al.
KIDNEY INTERNATIONAL (2009)
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes
Elena Gagliardini et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
Kathryn M. Thrailkill et al.
ENDOCRINE (2009)
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Joseph D. Raffetto et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Molecular mechanisms of proteinuria in diabetes
Luigi Gnudi
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
Ching-Hsin Ku et al.
DIABETES (2008)
Semaphorin3a disrupts podocyte foot processes causing acute proteinuria
R. Tapia et al.
KIDNEY INTERNATIONAL (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
Andrew Advani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease
Takahiko Nakagawa
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice
Yukiko Kanetsuna et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Endothelial nitric oxide is not involved in circadian rhythm generation of blood pressure: Experiments in wild-type C57 and eNOS knock-out mice under light-dark and free-run conditions
M. Arraj et al.
CHRONOBIOLOGY INTERNATIONAL (2007)
Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury
Michael S. Forbes et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Cellular and molecular mechanisms of proteinuria in diabetic nephropathy
Gunter Wolf et al.
NEPHRON PHYSIOLOGY (2007)
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice
Sun Hee Sung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP
Fangxia Guan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival
F Guan et al.
KIDNEY INTERNATIONAL (2006)
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes
MLP Gross et al.
LABORATORY INVESTIGATION (2006)
High ambient glucose levels modulates the production of MMP-9 and alpha 5(IV) collagen by cultured podocytes
YL Bai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model
K Ichinose et al.
DIABETES (2005)
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
RC Atkins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Mouse models of diabetic nephropathy
MD Breyer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes
E Bortoloso et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
A simplified method for HPLC determination of creatinine in mouse serum
PST Yuen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
BF Schrijvers et al.
KIDNEY INTERNATIONAL (2004)
Nephrin expression is reduced in human diabetic nephropathy - Evidence for a distinct role for glycated albumin and angiotensin II
S Doublier et al.
DIABETES (2003)
Vascular endothelial growth factor in diabetic nephropathy
T Lenz et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2003)
Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney
Guillermo Villegas et al.
MECHANISMS OF DEVELOPMENT (2002)
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy:: effects of angiotensin converting enzyme inhibition
RG Langham et al.
DIABETOLOGIA (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
P Hovind et al.
KIDNEY INTERNATIONAL (2000)
分享论文
